Comparative Effects of Estrogen and Raloxifene on B Lymphopoiesis and Bone Loss Induced by Sex Steroid Deficiency in Mice
暂无分享,去创建一个
Chisato Miyaura | Hiroaki Ohta | Masako Ito | S. Nozawa | Masako Ito | C. Miyaura | T. Suda | Shiro Nozawa | Tatsuo Suda | Yoshiko Onoe | Y. Onoe | H. Ohta
[1] N. Udagawa,et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] K. Korach,et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. , 1998, Journal of immunology.
[4] E. Puscheck,et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Gustafsson,et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary , 2022 .
[6] T. Martin,et al. Modulation of osteoclast differentiation. , 1992, Endocrine reviews.
[7] J. Corton,et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.
[8] S. Nozawa,et al. Expression of Estrogen Receptor β in Rat Bone. , 1997, Endocrinology.
[9] R. Turner,et al. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. , 1998, Endocrinology.
[10] T. Lebien,et al. Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes. , 1995, Journal of immunology.
[11] J. Polman,et al. ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .
[12] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.
[14] C. Christiansen,et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. , 1997, The New England journal of medicine.
[15] A. Glasebrook,et al. Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and Raloxifene , 1996, Science.
[16] Toshitaka Nakamura,et al. Osteoblasts are regulated by the cellular adhesion through ICAM‐1 and VCAM‐1 , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] Y. Onoe. Expression of Estrogen Receptor in Rat Bone , 1997 .
[18] H. Bryant,et al. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] T. Hirano,et al. IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.
[20] R. Thompson,et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. , 1994, The Journal of clinical investigation.
[21] S. Nozawa,et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. , 1996, Journal of immunology.
[22] C. Turner,et al. Raloxifene preserves bone strength and bone mass in ovariectomized rats. , 1994, Endocrinology.
[23] M. Kleerekoper,et al. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. , 1983, The Journal of clinical investigation.
[24] R. Turner,et al. The effects of raloxifene on tibia histomorphometry in ovariectomized rats. , 1994, Endocrinology.
[25] J. Gustafsson,et al. Estrogen receptor-beta mRNA expression in rat ovary: down-regulation by gonadotropins. , 1997, Molecular endocrinology.
[26] R. Kitazawa,et al. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. , 1994, The Journal of clinical investigation.
[27] S. Morony,et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.
[28] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[29] J. Kanis. Osteoporosis and osteopenia , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] R. Turner,et al. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. , 1996, Endocrinology.
[31] J. Corton,et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.
[32] Y. Koishihara,et al. Endogenous bone‐resorbing factors in estrogen deficiency: Cooperative effects of IL‐1 and IL‐6 , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] R. Turner,et al. Orchiectomy Markedly Reduces the Concentration of the Three Isoforms of Transforming Growth Factor β in Rat Bone, and Reduction Is Prevented by Testosterone. , 1998, Endocrinology.
[34] C. Wilson,et al. Enhanced production of B lymphocytes after castration. , 1995, Blood.
[35] K. Ikuta,et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[36] G. Prins,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Estrogen Receptor- � Messenger Ribonucleic Acid Ontogeny in the Prostate of Normal and Neonatally , 2022 .
[37] G. Passeri,et al. Interleukin-11: a new cytokine critical for osteoclast development. , 1994, The Journal of clinical investigation.
[38] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[39] S. Nozawa,et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. , 1994, The Journal of clinical investigation.
[40] D. Williams,et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. , 1994, The Journal of clinical investigation.